The patented dressing product will aid in the management of chronic wounds like diabetic foot ulcers
Healthium Medtech has launched a new wound dressing portfolio Theruptor Novo for the management of chronic wounds like diabetic foot ulcers and leg ulcers. With the launch of Theruptor Novo, Healthium strengthens its existing portfolio of patented products in the advanced wound dressing segment. Theruptor Novo is a best-in-class patented product which provides an optimum healing environment and addresses the concerns of the chronic wound dressing.
Theruptor Novo is an anti-microbial and non-toxic wound dressing with technology patented in the US, India, the EU and Canada. The product works on a physical kill mechanism of attracting, bind and rupturing formula – a patented technology that minimises the development of resistant microbes and aids in the healing process. The entire dressing has positively charged cationic sites, which attract the negatively charged microbes and ruptures their cell walls effectively, thus achieving anti-microbial protection. The anti-microbial technology is non-interfering and it doesn’t enter into the wound bed, making it persistent and effective for up to seven days.
Speaking on the launch, Anish Bafna, CEO and MD, Healthium Medtech, said, “It gives us immense pleasure to launch Theruptor Novo using our indigenous patented technology. This is another great addition to our robust and dynamic product portfolio in the wound care and infection prevention segment. We will continue to add value to our customers by manufacturing high-quality precision-based devices and products that address the unmet gaps and bring patient safety to the fore. We will strive towards strengthening our presence, expand our product portfolio and deliver better patient care worldwide.”
Dr Ashok Moharana, Chief Medical Officer, Healthium Medtech further adds, “The launch of Theruptor Novo reinforces our commitment towards precision products for clinicians and the patient community. At Healthium we are immensely focused on innovation, safety, quality and research for holistic solutions towards the clinical and patient community. Theruptor Novo is a patented product for the management of chronic wounds which acts through a unique physical mechanism of action, as against most of the available dressings which act through the pharmacological mechanism. The unique 3-D Hydrocellular substrate enables wicking action facilitating adequate exudate and moisture management and provides an optimal wound healing environment.”
